NEP has been suggested as a potential therapeutic because it cleaves a wide range of physiological peptide substrates including Aβ, which is thought to be a key pathological component of Alzheimer’s disease. The gene discussed is MME; the disease is early-onset autosomal dominant Alzheimer disease.